Ann-Louise Batchelor - 12 Sep 2022 Form 3 Insider Report for VOLITIONRX LTD (VNRX)

Role
Group Chief Marketing Officer
Signature
/s/ Ann-Louise Batchelor
Issuer symbol
VNRX
Transactions as of
12 Sep 2022
Net transactions value
$0
Form type
3
Filing time
14 Sep 2022, 16:05:31 UTC
Next filing
14 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VNRX Common Stock 18,908 12 Sep 2022 Direct F1
holding VNRX Common Stock 29,406 12 Sep 2022 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VNRX Stock Option (Right to Buy) 12 Sep 2022 Common Stock 50,000 $4.00 By Spouse
holding VNRX Stock Option (Right to Buy) 12 Sep 2022 Common Stock 31,126 $4.00 Direct
holding VNRX Stock Option (Right to Buy) 12 Sep 2022 Common Stock 40,000 $3.25 By Spouse
holding VNRX Stock Option (Right to Buy) 12 Sep 2022 Common Stock 50,000 $5.00 Direct
holding VNRX Stock Option (Right to Buy) 12 Sep 2022 Common Stock 18,874 $4.38 Direct
holding VNRX Stock Option (Right to Buy) 12 Sep 2022 Common Stock 55,000 $3.60 Direct
holding VNRX Stock Option (Right to Buy) 12 Sep 2022 Common Stock 22,229 $3.40 Direct
holding VNRX Stock Option (Right to Buy) 12 Sep 2022 Common Stock 22,228 $3.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12,062 restricted stock units subject to vesting on August 3, 2023. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.